Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of medical testing solutions specialist Quidel
So what: This is a one-two combination: Quidel reported analyst-crushing third-quarter revenues with an adequately small net loss and also announced FDA clearance to sell a new line of fluorescent flu-virus detectors.
Now what: The Sofia flu tester was approved for European sales in August, so production lines are already rolling. Fellow diagnostic-equipment expert Alere
Interested in more info about Quidel? Add it to My Watchlist.
Fool contributor Anders Bylund holds no position in any of the companies mentioned. We Fools don't all hold the same opinion, but we all believe that considering a diverse range of insights makes us better investors. Check out Anders' holdings and bio, or follow him on Twitter and Google+. We have a disclosure policy.